CVD & Primary Care: The need for EPCCS Practice Guidance

The EPCCS board and council members have recently convened to address critical needs supporting primary care professionals in managing the increasing burden of cardiovascular disease. As one of our primary initiatives, we are launching Practice Guidance based on the latest specialist guidelines.

GPcardio and ACC’s NCD Academy Join Forces to Strengthen Primary Care in Cardiovascular Disease Prevention

GPcardio is proud to announce a new strategic agreement with the NCD Academy, a global education platform developed by the American College of Cardiology (ACC). This collaboration marks an important milestone in our mission to empower primary care professionals across Europe in preventing and managing cardiovascular disease (CVD) and other non-communicable diseases (NCDs)

GPcardio - EPCCS Joins EACH in European Alliance for Cardiovascular Health

We are excited to announce that GPcardio, as initiative of the European Primary Care Cardiovascular Society (EPCCS) has joined EACH, the European Alliance for Cardiovascular Health

Introducing GPcardio: Bridging the Gap in Cardiovascular Care

Initiative from EPCCS: European Primary care Cardiovascular Scioety

We're excited to announce GPcardio, a vital new initiative from the European and International Primary Care Cardiovascular Societies (EPCCS & IPCCS). GPcardio is dedicated to transforming how evidence-based cardiovascular disease (CVD) management is adopted and implemented in primary care.

Web app effective in determining access to statins without a prescription

In a recent study presented at ACC.24, it was found that over 90% of patients correctly identified their suitability for nonprescription access to low-dose rosuvastatin using an innovative web application. This treatment proved to be safe overall and resulted in a significant 36% reduction in LDL cholesterol levels.

Enhanced remote medication program boosts GDMT prescriptions for high CV or kidney risk in T2D patients

At ACC.24, Dr. Alexander Blood shared insights from the DRIVE study, which examined the effectiveness of a remote program integrating patient education and medication management in increasing prescriptions for SGLT2 inhibitors and GLP-1RAs among type 2 diabetes (T2D) patients at elevated cardiovascular (CV) and/or renal risk

Gamification and financial incentives to increase physical activity among patients at elevated CV risk

At ACC.24, Dr. Alexander Fanaroff presented findings from the BE ACTIVE trial, demonstrating how gamification and financial incentives effectively boosted physical activity among patients at risk for cardiovascular events over a 12-month intervention period.

EPCCS consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care

General practitioners representing various European countries discussed recent developments in the SPAF field, and specific implications for primary care in an expert meeting. This meeting resulted in a practical guidance for European GPs.